Peptide

Testagen

Also known as

KEDG peptide · KEDG · Lys-Glu-Asp-Gly · H-Lys-Glu-Asp-Gly-OH · H-KEDG-OH · testicular bioregulator · Testagen Cytogen · Anterior Pituitary Peptide (APP) (vendor label discussions) · Khavinson testis tetrapeptide · testis peptide bioregulator

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

KEDG peptide	A synthetic four-amino-acid peptide discussed for libido, energy and natural-testosterone support. It is not established as testosterone replacement or a fertility treatment.
Names and forms differ	Testoluten is a testicular extract, while Testagen TDS-Testosterone is an unrelated hormone spray. Capsules, KEDG vials and minority spray/sublingual forms are not equivalent exposures.

Notes

Testagen is the synthetic four-amino-acid peptide KEDG, discussed for libido, energy and supporting natural testosterone. Reports range from feeling better without changed testosterone to no noticeable benefit. It has not been established as a replacement for testosterone treatment or a fertility treatment.

KEDG means lysine, glutamic acid, aspartic acid and glycine. Bioregulator talk describes short peptides influencing cells. Reproductive marketing dominates discussion, but the inspected animal paper modeled KEDG on anterior-pituitary extracts. That does not establish a human testosterone effect. Kuznik et al.: KEDG and AEDG in hypophysectomized chickens and hens (Animal context · Accessed 2026-09-30)

Testagen, Testoluten and testosterone are different products. The community record distinguishes synthetic KEDG from Testoluten testicular extract. Testagen TDS-Testosterone is an unrelated hormone spray. Oral capsules, injected powder and minority sublingual, spray or drop forms cannot be treated as equal exposure. EU Clinical Trials Register: Testagen TDS-Testosterone5% (Official context · Accessed 2026-09-30)

Source context — Kuznik et al.: KEDG and AEDG in hypophysectomized chickens and hens: Abstract only; two peptides and surgically altered birds. Not human testosterone, fertility, clearance or oral-versus-injected evidence.

Source context — EU Clinical Trials Register: Testagen TDS-Testosterone5%: Name collision only; no efficacy, regulatory status or PK transferred to the peptide.

What people notice

Libido, energy or gym drive	Some describe stronger libido or energy. One multi-agent user felt stronger while total testosterone remained in the low 700s, with units unstated.
Modest or no result	An injection user reported better energy but only slight libido change and questioned the cost. Other oral and Testagen/Prostamax reports describe no noticeable benefit.
Hormone claims	Better mood, sex drive or semen appearance does not establish higher testosterone, improved sperm or a fertility outcome.

Notes

Libido, energy and gym drive are the main reported attractions. One 54-year-old poster described nighttime erections without bloodwork. Others seek natural-T support, thyroid improvement or fertility preservation while avoiding TRT; those goals do not demonstrate higher testosterone, better sperm or successful pregnancies. Testagen: perceived testosterone without bloodwork (Personal report · Accessed 2026-09-30)

Feeling stronger did not mean testosterone rose. The changing 2 mg reporter described libido, energy and strength gains while total testosterone stayed in the low 700s, units unstated. Reta, CJC with Ipamorelin, MOTS-c, and occasional BPC-157 with TB-500 were also used. Testagen peptide: promotional opening and one changing three-month log (Community discussion · Accessed 2026-09-30)

A modest lab change left one person questioning the cost. An injection user reported 419 in January 2025 and 487 in October after 4½ weeks at 2 mg/day; units were unstated. Energy improved, libido only slightly, and spending over $200/month felt questionable. The duplicated update is one story; months-apart tests cannot isolate causation. Testagen: oral experience, injection log and mixed follow-ups (Community discussion · Accessed 2026-09-30)

Oral convenience and libido praise sit beside no benefit. A capsule user described better libido and semen quality, without sperm testing. Another respondent reported nothing noticeable and poor value. A capsule claim of equal bioavailability was opinion, not a comparison study. Testagen: oral experience, injection log and mixed follow-ups (Community discussion · Accessed 2026-09-30)

More peptide did not rescue one unsuccessful combined experiment. A Testagen/Prostamax poster described two 20-day SubQ blocks separated by a month and no noticeable result. Earlier wording called the higher 4 mg/day a combined total; the follow-up was ambiguous. It cannot become a verified 4 mg Testagen-alone dose. Bioregulator Peptides: Testagen/Prostamax no-response follow-up (Community discussion · Accessed 2026-09-30)

Thyroid and reproductive claims remain hypotheses. The proposed pituitary–thyroid link helps explain the marketing. It does not establish treatment of hypothyroidism, prostatitis, hypogonadism or infertility. Better mood or sex drive alone cannot verify an endocrine change.

Source context — Testagen: perceived testosterone without bloodwork: Subjective sexual response is not measured testosterone; route, product, onset and co-exposures absent.

Source context — Testagen peptide: promotional opening and one changing three-month log: Commercially promoted opening is not efficacy evidence. One author, changing schedule, injection subtype and lab units unstated; Reta, CJC/Ipamorelin, MOTS-c and BPC-157/TB-500 confound attribution. Planned breaks are not observed off-course results.

Source context — Testagen: oral experience, injection log and mixed follow-ups: Vendor-named subreddit; unverified products/labs. Two copies of the same 419-to-487 story are one account. Lab units absent; baseline January and follow-up October 2025 are months apart. Some replies remain collapsed.

Source context — Bioregulator Peptides: Testagen/Prostamax no-response follow-up: Poster calls the recipient a lab rat/test subject, so species and whether amounts are per peptide are not verified. Earlier post calls4mg/day a total; later follow-up omits that qualifier. No bloodwork or controlled fertility outcomes.

Doses people talk about

Microgram chart	100–300 mcg once daily SubQ is an aggregator-chart band, separate from milligram accounts.
Daily short-course amounts	1–2 mg/day SubQ or intramuscularly for 10–20 days appears in earlier notes. One poster explicitly described 2 mg SubQ daily for 20 days without explaining the claimed benefit.
Non-daily injection account	One user reported 2 mg per injection Monday/Wednesday/Friday, then every three days, then Monday/Wednesday/Friday again. Injection subtype was unstated; it was not 2 mg daily.
Oral counts and other claims	1–2 capsules once or twice daily appears in older oral talk, without pure KEDG equivalence. Secondhand 500 mcg and formulation-dependent multi-mg claims are different records.
Units and combined totals	1 mg equals 1,000 mcg; syringe units measure volume. The higher Testagen/Prostamax follow-up is ambiguous and cannot establish 4 mg/day of Testagen alone.

Notes

100–300 mcg once daily SubQ: an aggregator chart. Pepbase lists this under community protocols; SubQ means under the skin. It is separate from milligram accounts. Pepbase: Testagen community charts and minute-scale claims (Community guide · Accessed 2026-09-30)

1–2 mg daily: short-course injection reports. The earlier record associates 1–2 mg SubQ or IM with 10–20 days; IM means into muscle. One poster explicitly reported 2 mg SubQ daily for 20 days, calling results decent without explaining the outcome. Testagen or Vilon Protocol: dose disagreements and route switching (Community discussion · Accessed 2026-09-30)

2 mg per injection, three times weekly or every three days. One author changed from Monday, Wednesday and Friday to every three days, then reported Monday, Wednesday and Friday again. Injection subtype was unstated; 2 mg was not a daily total. Testagen peptide: promotional opening and one changing three-month log (Community discussion · Accessed 2026-09-30)

Capsule counts are not pure KEDG milligrams. Earlier oral talk lists 1–2 capsules once or twice daily; a general bioregulator commenter described 2 capsules/day. Neither establishes equivalent exposure to injections. Secondhand 500 mcg reports, tentative 5 mg IM suggestions and unlinked clinic language around 10 mg/day have different or unclear formulations. Bioregulator Peptides: oral-course opinion and dose confusion (Community discussion · Accessed 2026-09-30) · Testagen or Vilon Protocol: dose disagreements and route switching (Community discussion · Accessed 2026-09-30)

Milligrams, micrograms and syringe units are different. 1 mg equals 1,000 mcg. The competing charts are not a titration ladder; a unit-marked syringe measures volume, not peptide mass.

Source context — Pepbase: Testagen community charts and minute-scale claims: Secondary aggregator says it does not verify protocols. No accessible route-specific human PK study supports minute figures; compilation mixes literature and community without linking each numeric claim.

Source context — Testagen or Vilon Protocol: dose disagreements and route switching: Thread covers two compounds. Sleep reports cannot confidently be assigned to Testagen. 500 mg reply excluded without silent unit correction. juniperstreet explicitly had not personally used Testagen; Naven71 never specifies the benefit.

Source context — Bioregulator Peptides: oral-course opinion and dose confusion: General bioregulator advice from someone using them with clients; not exact Testagen product composition. No independent substantiation for all-human-data-oral, no-sides or universal tissue targeting.

Half-life, onset & duration

Felt onset	Second-week energy and week-three changes appear in separate logs. No single-dose onset is measured.
Felt duration	No dependable per-dose or after-course window. Feeling better during three months of ongoing stacked use is not three months of benefit after stopping.
Half-life	About 30 minutes is an unvalidated aggregator estimate, alongside 15-minute peak and 2.5-hour clearance claims. Human route-specific clearance remains unknown.

Notes

Second-week energy in one log; week-three changes in another. Neither measured the first effect of a single dose. A Testagen/kisspeptin user noticed no clear difference after two weeks. Testagen: oral experience, injection log and mixed follow-ups (Community discussion · Accessed 2026-09-30) · Testagen peptide: promotional opening and one changing three-month log (Community discussion · Accessed 2026-09-30) · TEST PEPTIDE STACK? (Community discussion · Accessed 2026-09-30)

No dependable single-dose duration is established. The stacked author felt better across roughly three months of ongoing use, then planned a break. That is not evidence of effects lasting three months after stopping. Testagen peptide: promotional opening and one changing three-month log (Community discussion · Accessed 2026-09-30)

After-course persistence is reported without a reliable window. An oral poster believed benefits continued for a while; the earlier record mentions days-to-weeks persistence. A Testagen/Prostamax account reported no effect during use or months afterward. Testagen: oral experience, injection log and mixed follow-ups (Community discussion · Accessed 2026-09-30) · Bioregulator Peptides: Testagen/Prostamax no-response follow-up (Community discussion · Accessed 2026-09-30)

About 30 minutes is an unvalidated circulated estimate. Pepbase also lists 15 minutes to peak and about 2.5 hours clearance without a human PK study supporting them. Human route-specific clearance remains unknown. Pepbase: Testagen community charts and minute-scale claims (Community guide · Accessed 2026-09-30)

Source context — TEST PEPTIDE STACK?: Route and kisspeptin frequency not specified in that reply. The OP's different kisspeptin schedule belongs to another person and is not combined. No subsequent bloodwork visible.

Cycles people discuss

Short-course patterns	10–20-day injection blocks and 20–30-day oral courses are distinct patterns. General oral-bioregulator advice also describes 10-day maintenance blocks every 3–6 months.
Longer chart patterns	Microgram charts span 4–6 weeks, 1–2 months, 8–12 or 8–16 weeks, with equal time off or longer gaps. These competing calendars do not establish an optimal safe cycle.
Planned versus observed break	One month on/one off and a later 1–2-month pause were plans in the changing 2 mg history; the inspected follow-ups do not establish their results.

Notes

10–20-day injection blocks; 20–30-day oral courses. These remain distinct earlier patterns. The oral-community commenter described 30 days initially and 10-day maintenance blocks repeated every 3–6 months; composition was unspecified. Bioregulator Peptides: oral-course opinion and dose confusion (Community discussion · Accessed 2026-09-30)

4–6 weeks, 1–2 months, 8–12 weeks and 8–16 weeks appear in charts. The unlinked microgram-chart family includes these competing lengths. Break talk spans equal time off, multi-month gaps and 2–4 courses/year; none establishes an optimal safe cycle.

One month on/one off was a plan, not a verified result. The changing 2 mg account continued posting ongoing use. A later planned one-to-two-month break had no inspected outcome update. Calendar talk should not be mistaken for proven recovery. Testagen peptide: promotional opening and one changing three-month log (Community discussion · Accessed 2026-09-30)

Stacks

Other bioregulators	Epitalon, Thymalin, Prostamax and Pinealon recur in pairing or organ-pack talk. Benefits cannot be assigned to Testagen alone.
Hormone-related combinations	Enclomiphene, kisspeptin, hCG and growth-hormone peptides appear, including a kisspeptin combination with no clear two-week change.
Larger recovery/metabolic stack	One positive history also used retatrutide, CJC/ipamorelin, MOTS-c and occasional BPC-157/TB-500. It cannot isolate Testagen's contribution.
Testoluten sequence and PCT	Oral Testagen followed by Testoluten extract is community sequencing lore. A sponsored post-cycle stack also added Testagen without an isolated recovery result.

Notes

Epitalon / Epithalon (longevity dual): Same calendar window or overlapping courses; example community template: Testagen ~100–200 mcg morning + Epitalon ~100–200 mcg evening × ~4–6 weeks, then off. Attribution of any benefit is confounded. [community]

Thymalin: Immune + endocrine dual for aging or chronic prostatitis-style narratives. [community]

Prostamax: Same course window for urogenital-directed Khavinson short-peptide pairing. [community]

Pinealon / other Cytogens: Full longevity “organ pack” talk (brain + pineal + testes). [community]

Route preferences and stacks add uncertainty. One Testagen/Vilon poster felt Testagen more with IM than SubQ but supplied no comparison labs. Previous discussion pairs Epitalon, Thymalin, Prostamax, Pinealon, enclomiphene, kisspeptin, hCG, growth-hormone peptides and BPC-157 with Testagen, alongside sleep, training and weight loss. Testagen or Vilon Protocol: dose disagreements and route switching (Community discussion · Accessed 2026-09-30)

HPG pharma adjuncts: Enclomiphene, kisspeptin analogs, or hCG co-discussed in “natural T” stacks — confounds labs and credit. [community]

GHRH-class: CJC-1295 / tesamorelin-class peptides when concurrent somatotropic support is the separate goal. [community]

Testagen-to-Testoluten sequencing and PCT are community ideas. The older record describes oral Testagen followed by extract maintenance. A sponsored PCT log adds 1 mg Testagen to a large stack, without an isolated result. Neither establishes reproductive recovery or superiority over hCG, kisspeptin or TRT. PCT Stack and Peptides Log, page2 (Personal report · Accessed 2026-09-30)

Source context — PCT Stack and Peptides Log, page2: Sponsored stack log; route/frequency unstated and sleep report precedes adding Testagen. No isolated Testagen result established on inspected page.

Watch for

Unwanted symptoms	Earlier notes include local irritation, headache, lightheadedness, fatigue, hunger and mood/libido shifts. The inspected logs do not establish their frequency or cause.
Endocrine and cancer concerns	Thyroid medicines, hyperthyroidism, hormone-sensitive cancers, pregnancy and breastfeeding are flagged as unresolved concerns rather than validated KEDG interaction rules.
Product and delayed diagnosis	Mislabeling, contamination and nonsterile vials matter. Experimentation can delay evaluation of low testosterone, infertility or pituitary/thyroid disease.

Notes

Local irritation, headaches and feeling flat are in the community record. Earlier summaries include redness, itch, tenderness, lightheadedness, fatigue, hunger and mood or libido shifts. The inspected logs do not establish their frequency or cause; reports of no side effects cannot prove safety.

Thyroid and hormone-sensitive conditions complicate the claims. The existing discussions flag thyroid medicines, hyperthyroidism, active or hormone-sensitive cancers, pregnancy and breastfeeding. These are caution narratives, not validated interaction or contraindication studies for KEDG.

An unverified product and a hormone symptom are separate problems. The record flags mislabeling, contamination and nonsterile vials. Peptide experimentation can also delay evaluation of low testosterone, infertility or pituitary/thyroid disease. Product testing would not establish clinical benefit.

Full notes

What Testagen is

KEDG means lysine, glutamic acid, aspartic acid and glycine. Bioregulator talk describes short peptides influencing cells. Reproductive marketing dominates discussion, but the inspected animal paper modeled KEDG on anterior-pituitary extracts. That does not establish a human testosterone effect. Animal context Community
Testagen, Testoluten and testosterone are different products. The community record distinguishes synthetic KEDG from Testoluten testicular extract. Testagen TDS-Testosterone is an unrelated hormone spray. Oral capsules, injected powder and minority sublingual, spray or drop forms cannot be treated as equal exposure. Community Official context

Why people look it up

Libido, energy and gym drive are the main reported attractions. One 54-year-old poster described nighttime erections without bloodwork. Others seek natural-T support, thyroid improvement or fertility preservation while avoiding TRT; those goals do not demonstrate higher testosterone, better sperm or successful pregnancies. Personal report Community
Thyroid and reproductive claims remain hypotheses. The proposed pituitary–thyroid link helps explain the marketing. It does not establish treatment of hypothyroidism, prostatitis, hypogonadism or infertility. Better mood or sex drive alone cannot verify an endocrine change. Community

Doses people discuss

100–300 mcg once daily SubQ: an aggregator chart. Pepbase lists this under community protocols; SubQ means under the skin. It is separate from milligram accounts. Community guide
1–2 mg daily: short-course injection reports. The earlier record associates 1–2 mg SubQ or IM with 10–20 days; IM means into muscle. One poster explicitly reported 2 mg SubQ daily for 20 days, calling results decent without explaining the outcome. Community Reddit
2 mg per injection, three times weekly or every three days. One author changed from Monday, Wednesday and Friday to every three days, then reported Monday, Wednesday and Friday again. Injection subtype was unstated; 2 mg was not a daily total. Reddit
Capsule counts are not pure KEDG milligrams. Earlier oral talk lists 1–2 capsules once or twice daily; a general bioregulator commenter described 2 capsules/day. Neither establishes equivalent exposure to injections. Secondhand 500 mcg reports, tentative 5 mg IM suggestions and unlinked clinic language around 10 mg/day have different or unclear formulations. Community Community Reddit Reddit
Milligrams, micrograms and syringe units are different. 1 mg equals 1,000 mcg. The competing charts are not a titration ladder; a unit-marked syringe measures volume, not peptide mass. Community

Half-life

About 30 minutes is an unvalidated circulated estimate. Pepbase also lists 15 minutes to peak and about 2.5 hours clearance without a human PK study supporting them. Human route-specific clearance remains unknown. Community guide

Onset: when changes are reported

Second-week energy in one log; week-three changes in another. Neither measured the first effect of a single dose. A Testagen/kisspeptin user noticed no clear difference after two weeks. Reddit Reddit Reddit
Days 4–10 and weeks 4–8 also circulate as expectations. The previous community summaries include early subtle changes, little immediate kick, and longer waiting periods. Those chart expectations are not measured onset windows or a promise. Community

Duration: how long changes last

No dependable single-dose duration is established. The stacked author felt better across roughly three months of ongoing use, then planned a break. That is not evidence of effects lasting three months after stopping. Reddit
After-course persistence is reported without a reliable window. An oral poster believed benefits continued for a while; the earlier record mentions days-to-weeks persistence. A Testagen/Prostamax account reported no effect during use or months afterward. Reddit Community Reddit

Cycles and time off

10–20-day injection blocks; 20–30-day oral courses. These remain distinct earlier patterns. The oral-community commenter described 30 days initially and 10-day maintenance blocks repeated every 3–6 months; composition was unspecified. Community Reddit
4–6 weeks, 1–2 months, 8–12 weeks and 8–16 weeks appear in charts. The unlinked microgram-chart family includes these competing lengths. Break talk spans equal time off, multi-month gaps and 2–4 courses/year; none establishes an optimal safe cycle. Community
One month on/one off was a plan, not a verified result. The changing 2 mg account continued posting ongoing use. A later planned one-to-two-month break had no inspected outcome update. Calendar talk should not be mistaken for proven recovery. Reddit

Good to know

Local irritation, headaches and feeling flat are in the community record. Earlier summaries include redness, itch, tenderness, lightheadedness, fatigue, hunger and mood or libido shifts. The inspected logs do not establish their frequency or cause; reports of no side effects cannot prove safety. Community
Thyroid and hormone-sensitive conditions complicate the claims. The existing discussions flag thyroid medicines, hyperthyroidism, active or hormone-sensitive cancers, pregnancy and breastfeeding. These are caution narratives, not validated interaction or contraindication studies for KEDG. Community
An unverified product and a hormone symptom are separate problems. The record flags mislabeling, contamination and nonsterile vials. Peptide experimentation can also delay evaluation of low testosterone, infertility or pituitary/thyroid disease. Product testing would not establish clinical benefit. Community

What people actually report

Feeling stronger did not mean testosterone rose. The changing 2 mg reporter described libido, energy and strength gains while total testosterone stayed in the low 700s, units unstated. Reta, CJC with Ipamorelin, MOTS-c, and occasional BPC-157 with TB-500 were also used. Reddit
A modest lab change left one person questioning the cost. An injection user reported 419 in January 2025 and 487 in October after 4½ weeks at 2 mg/day; units were unstated. Energy improved, libido only slightly, and spending over $200/month felt questionable. The duplicated update is one story; months-apart tests cannot isolate causation. Reddit
Oral convenience and libido praise sit beside no benefit. A capsule user described better libido and semen quality, without sperm testing. Another respondent reported nothing noticeable and poor value. A capsule claim of equal bioavailability was opinion, not a comparison study. Reddit
More peptide did not rescue one unsuccessful combined experiment. A Testagen/Prostamax poster described two 20-day SubQ blocks separated by a month and no noticeable result. Earlier wording called the higher 4 mg/day a combined total; the follow-up was ambiguous. It cannot become a verified 4 mg Testagen-alone dose. Reddit
Route preferences and stacks add uncertainty. One Testagen/Vilon poster felt Testagen more with IM than SubQ but supplied no comparison labs. Previous discussion pairs Epitalon, Thymalin, Prostamax, Pinealon, enclomiphene, kisspeptin, hCG, growth-hormone peptides and BPC-157 with Testagen, alongside sleep, training and weight loss. Reddit Community
Testagen-to-Testoluten sequencing and PCT are community ideas. The older record describes oral Testagen followed by extract maintenance. A sponsored PCT log adds 1 mg Testagen to a large stack, without an isolated result. Neither establishes reproductive recovery or superiority over hCG, kisspeptin or TRT. Community Personal report
Morning timing and blood panels are discussion habits. Earlier notes favor morning injections and disagree about oral use before meals or with food. People compare total/free testosterone, LH, FSH, SHBG, estradiol and thyroid panels; neither a preferred clock time nor feeling better validates the claim. Community Community

Where the thyroid story comes from

A thyroid finding in birds. A 2011 abstract reports improved thyroid measures after 40 days of KEDG and AEDG in birds lacking a pituitary, with weaker effects in older birds. Human outcomes were not tested. Animal context